Role of SIRT1 and Progesterone Resistance in Normal and Abnormal Endometrium

J Clin Endocrinol Metab. 2022 Feb 17;107(3):788-800. doi: 10.1210/clinem/dgab753.

Abstract

Context: Progesterone resistance, a known pathologic condition associated with a reduced cellular response to progesterone and heightened estrogen responses, appears to have a normal physiologic role in mammalian reproduction. The molecular mechanism responsible for progesterone resistance in normal and abnormal endometrium remains unclear.

Objective: To examine the roles of sirtuin-1 (SIRT1) in normal endometrium as well as endometrium associated with infertility and endometriosis, as an epigenetic modulator associated with progesterone resistance.

Methods: SIRT1 expression was examined by Western blot, quantitative real-time polymerase chain reaction, and immunohistochemistry in mouse uterus and human endometrium. Mice with uterine specific Sirt1 overexpression were developed to examine SIRT1's role in endometrial function and endometriosis development. EX-527, a SIRT1 inhibitor, and SRT1720, a SIRT1 agonist, were also used to evaluate SIRT1 effect on endometriosis.

Results: In normal healthy women, endometrial SIRT1 is expressed only during menses. SIRT1 was dramatically overexpressed in the endometrium from women with endometriosis in both the epithelium and stroma. In mice, SIRT1 is expressed at the time of implantation between day 4.5 and 5.5 of pregnancy. Overexpression of SIRT1 in the mouse uterus leads to subfertility due to implantation failure, decidualization defects and progesterone resistance. SIRT1 overexpression in endometriotic lesions promotes worsening endometriosis development. EX-527 significantly reduced the number of endometriotic lesions in the mouse endometriosis model.

Conclusions: SIRT1 expression and progesterone resistance appears to play roles in normal endometrial functions. Aberrant SIRT1 expression contributes to progesterone resistance and may participate in the pathophysiology of endometriosis. SIRT1 is a novel and targetable protein for the diagnosis as well as treatment of endometriosis and the associated infertility seen in this disease.

Keywords: endometriosis; endometrium; epigenetics; implantation; infertility; progesterone.

Publication types

  • Observational Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Animals
  • Carbazoles / pharmacology
  • Carbazoles / therapeutic use
  • Case-Control Studies
  • Disease Models, Animal
  • Embryo Implantation / genetics
  • Endometriosis / drug therapy
  • Endometriosis / genetics*
  • Endometriosis / pathology
  • Endometrium / abnormalities*
  • Endometrium / drug effects
  • Endometrium / pathology
  • Epigenesis, Genetic
  • Female
  • Heterocyclic Compounds, 4 or More Rings / pharmacology
  • Heterocyclic Compounds, 4 or More Rings / therapeutic use
  • Humans
  • Infertility, Female / genetics*
  • Menstruation / genetics
  • Mice
  • Mice, Transgenic
  • Middle Aged
  • Progesterone / metabolism
  • Sirtuin 1 / antagonists & inhibitors
  • Sirtuin 1 / genetics*
  • Uterine Diseases / complications
  • Uterine Diseases / genetics*
  • Uterine Diseases / pathology
  • Young Adult

Substances

  • 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide
  • Carbazoles
  • Heterocyclic Compounds, 4 or More Rings
  • SRT1720
  • Progesterone
  • SIRT1 protein, human
  • Sirt1 protein, mouse
  • Sirtuin 1

Supplementary concepts

  • Progesterone Resistance